Callander GE - Search Results

1

Prolonged RXFP1 and RXFP2 signaling can be explained by poor internalization and a lack of beta-arrestin recruitment.

Callander GE, Thomas WG, Bathgate RA. Callander GE, et al. Am J Physiol Cell Physiol. 2009 May;296(5):C1058-66. doi: 10.1152/ajpcell.00581.2008. Epub 2009 Mar 11. Am J Physiol Cell Physiol. 2009. PMID: 19279230 Free article.

2

Relaxin family peptide systems and the central nervous system.

Callander GE, Bathgate RA. Callander GE, et al. Cell Mol Life Sci. 2010 Jul;67(14):2327-41. doi: 10.1007/s00018-010-0304-z. Epub 2010 Mar 7. Cell Mol Life Sci. 2010. PMID: 20213277 Free PMC article. Review.

3

Resolving the unconventional mechanisms underlying RXFP1 and RXFP2 receptor function.

Hartley BJ, Scott DJ, Callander GE, Wilkinson TN, Ganella DE, Kong CK, Layfield S, Ferraro T, Petrie EJ, Bathgate RA. Hartley BJ, et al. Among authors: callander ge. Ann N Y Acad Sci. 2009 Apr;1160:67-73. doi: 10.1111/j.1749-6632.2009.03949.x. Ann N Y Acad Sci. 2009. PMID: 19416161

4

Modulation of feeding by chronic rAAV expression of a relaxin-3 peptide agonist in rat hypothalamus.

Ganella DE, Callander GE, Ma S, Bye CR, Gundlach AL, Bathgate RA. Ganella DE, et al. Among authors: callander ge. Gene Ther. 2013 Jul;20(7):703-16. doi: 10.1038/gt.2012.83. Epub 2012 Nov 8. Gene Ther. 2013. PMID: 23135160

5

Relaxin family peptides and their receptors.

Bathgate RA, Halls ML, van der Westhuizen ET, Callander GE, Kocan M, Summers RJ. Bathgate RA, et al. Among authors: callander ge. Physiol Rev. 2013 Jan;93(1):405-80. doi: 10.1152/physrev.00001.2012. Physiol Rev. 2013. PMID: 23303914 Free article. Review.

6

Development and optimization of microRNA against relaxin-3.

Callander GE, Thomas WG, Bathgate RA. Callander GE, et al. Ann N Y Acad Sci. 2009 Apr;1160:261-4. doi: 10.1111/j.1749-6632.2008.03816.x. Ann N Y Acad Sci. 2009. PMID: 19416200

7

Silencing relaxin-3 in nucleus incertus of adult rodents: a viral vector-based approach to investigate neuropeptide function.

Callander GE, Ma S, Ganella DE, Wimmer VC, Gundlach AL, Thomas WG, Bathgate RA. Callander GE, et al. PLoS One. 2012;7(8):e42300. doi: 10.1371/journal.pone.0042300. Epub 2012 Aug 2. PLoS One. 2012. PMID: 22876314 Free PMC article.

8

Development of human cells with RXFP1 knockdown using retroviral delivery of microRNA against human RXFP1.

Yong KL, Callander GE, Bergin R, Samuel CS, Bathgate RA. Yong KL, et al. Among authors: callander ge. Ital J Anat Embryol. 2013;118(1 Suppl):10-2. Ital J Anat Embryol. 2013. PMID: 24640558

9

Suvorexant for the treatment of insomnia.

Jacobson LH, Callander GE, Hoyer D. Jacobson LH, et al. Among authors: callander ge. Expert Rev Clin Pharmacol. 2014 Nov;7(6):711-30. doi: 10.1586/17512433.2014.966813. Expert Rev Clin Pharmacol. 2014. PMID: 25318834 Review.

10

Kinetic properties of "dual" orexin receptor antagonists at OX1R and OX2R orexin receptors.

Callander GE, Olorunda M, Monna D, Schuepbach E, Langenegger D, Betschart C, Hintermann S, Behnke D, Cotesta S, Fendt M, Laue G, Ofner S, Briard E, Gee CE, Jacobson LH, Hoyer D. Callander GE, et al. Front Neurosci. 2013 Dec 3;7:230. doi: 10.3389/fnins.2013.00230. eCollection 2013. Front Neurosci. 2013. PMID: 24376396 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page